Literature DB >> 12837616

Antibodies in proteomics II: screening, high-throughput characterization and downstream applications.

Andrew Bradbury1, Nileena Velappan, Vittorio Verzillo, Milan Ovecka, Leslie Chasteen, Daniele Sblattero, Roberto Marzari, Jianlong Lou, Robert Siegel, Peter Pavlik.   

Abstract

There are many ways in which the use of antibodies and antibody selection can be improved and developed for high-throughput characterization. Standard protocols, such as immunoprecipitation, western blotting and immunofluorescence, can be used with antibody fragments generated by display technologies. Together with novel approaches, such as antibody chips and intracellular immunization, these methods will yield useful proteomic data following adaptation of the protocols for increased reliability and robustness. To date, most work has focused on the use of standard, well-characterized commercial antibodies. Such protocols need to be adapted for broader use, for example, with antibody fragments or other binders generated by display technologies, because it is unlikely that traditional approaches will provide the required throughput.

Mesh:

Substances:

Year:  2003        PMID: 12837616     DOI: 10.1016/S0167-7799(03)00117-3

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  8 in total

1.  APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering.

Authors:  Ki Jun Jeong; Min Jeong Seo; Brent L Iverson; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

2.  By-passing in vitro screening--next generation sequencing technologies applied to antibody display and in silico candidate selection.

Authors:  U Ravn; F Gueneau; L Baerlocher; M Osteras; M Desmurs; P Malinge; G Magistrelli; L Farinelli; M H Kosco-Vilbois; N Fischer
Journal:  Nucleic Acids Res       Date:  2010-09-15       Impact factor: 16.971

3.  Generating conformation-specific synthetic antibodies to trap proteins in selected functional states.

Authors:  Marcin Paduch; Akiko Koide; Serdar Uysal; Shahir S Rizk; Shohei Koide; Anthony A Kossiakoff
Journal:  Methods       Date:  2012-12-29       Impact factor: 3.608

4.  Eliminating helper phage from phage display.

Authors:  L Chasteen; J Ayriss; P Pavlik; A R M Bradbury
Journal:  Nucleic Acids Res       Date:  2006-11-06       Impact factor: 16.971

5.  Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models.

Authors:  Roberto Di Niro; Federica Ziller; Fiorella Florian; Sergio Crovella; Marco Stebel; Marco Bestagno; Oscar Burrone; Andrew R M Bradbury; Paola Secco; Roberto Marzari; Daniele Sblattero
Journal:  BMC Biotechnol       Date:  2007-08-01       Impact factor: 2.563

Review 6.  Antibody Engineering for Pursuing a Healthier Future.

Authors:  Abdullah F U H Saeed; Rongzhi Wang; Sumei Ling; Shihua Wang
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

7.  A compact phage display human scFv library for selection of antibodies to a wide variety of antigens.

Authors:  Potjamas Pansri; Nanthnit Jaruseranee; Kuntalee Rangnoi; Peter Kristensen; Montarop Yamabhai
Journal:  BMC Biotechnol       Date:  2009-01-29       Impact factor: 2.563

8.  Fluorescence ImmunoPrecipitation (FLIP): a Novel Assay for High-Throughput IP.

Authors:  Paolo Mita; Tenzin Lhakhang; Donghui Li; Daniel J Eichinger; David Fenyo; Jef D Boeke
Journal:  Biol Proced Online       Date:  2016-08-15       Impact factor: 3.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.